The Bruton's tyrosine kinase (BTK) inhibitor PCI-32765 (P) in treatment-naive (TN) chronic lymphocytic leukemia (CLL) patients (pts): Interim results of a phase Ib/II study.
John C. Byrd
Research Funding - Pharmacyclics
Richard R. Furman
Research Funding - Pharmacyclics
Steven E. Coutre
Research Funding - Pharmacyclics
Jan Andreas Burger
Research Funding - Pharmacyclics
Kristie A. Blum
Research Funding - Pharmacyclics
Jeff Porter Sharman
Research Funding - Pharmacyclics
Ian W. Flinn
Research Funding - Pharmacyclics
Barbara W. Grant
Research Funding - Pharmacyclics
Nyla A. Heerema
No relevant relationships to disclose
Amy J Johnson
No relevant relationships to disclose
Tasheda Navarro
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
Danelle Frances James
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
Eric Hedrick
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
Susan Mary O'Brien
Research Funding - Pharmacyclics